Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oral contraceptives

Executive Summary

April 8 letter from FDA to companies requests all oral contraceptive labeling be changed within the next six months to include a statement that the product "is intended to prevent pregnancy" and "does not protect against HIV infection (AIDS) and other sexually transmitted disease." In addition, the statement is to be printed on contraceptive packaging with an expanded statement appearing in the patient package insert that lists types of STDs. Similar labeling will be required for Norplant, Depo Provera and IUDs.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS022438

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel